An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288 in Sleep Apnea Patients

Trial Profile

An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288 in Sleep Apnea Patients

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs MK 7288 (Primary) ; Modafinil
  • Indications Sleep apnoea syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 18 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 12 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top